Intensity modulated radiotherapy (IMRT) has become a treatment of choice in many oncological institutions. Small fields or beamlets with sizes of 1 to 5 cm 2 are now routinely used in IMRT delivery. Therefore small ionization chambers (IC) with sensitive volumes 0.1 cm 3 are generally used for dose verification of an IMRT treatment. The measurement conditions during verification may be quite different from reference conditions normally encountered in clinical beam calibration, so dosimetry of these narrow photon beams pertains to the so-called non-reference conditions for beam calibration. This work aims at estimating the error made when measuring the organ at risk's (OAR) absolute dose by a micro ion chamber (µIC) in a typical IMRT treatment. The dose error comes from the assumption that the dosimetric parameters determining the absolute dose are the same as for the reference conditions. We have selected two clinical cases, treated by IMRT, for our dose error evaluations. Detailed geometrical simulation of the µIC and the dose verification set-up was performed. The Monte Carlo (MC) simulation allows us to calculate the dose measured by the chamber as a dose averaged over the air cavity within the ion-chamber active volume (D air ). The absorbed dose to water (D water ) is derived as the dose deposited inside the same volume, in the same geometrical position, filled and surrounded by water in the absence of the ion chamber. Therefore, the D water /D air dose ratio is the MC estimator of the total correction factor needed to convert the absorbed dose in air into the absorbed dose in water. The dose ratio was calculated for the µIC located at the isocentre within the OARs for both clinical cases. The clinical impact
of the calculated dose error was found to be negligible for the studied IMRT treatments.
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Introduction
Intensity modulated radiotherapy (IMRT) offers a significant advance in conformal therapy, by reducing radiation dose to organs at risk (OAR) close to, or even within a concavity of, the planning target volume (PTV). Significant normal tissue sparing using IMRT allows target dose escalation and increased cure rates.
Treatment planning systems (TPS) cannot yet consider many effects of transmission through multileaf collimator systems in order to provide accurate dosimetry for IMRT treatments. Significant differences might be found between the measured and TPS calculated dose, especially in the high dose gradient region in the vicinity of critical structures (Van Dyk et al 1993 , Cadman et al 2002 . These results substantiate the need for stringent in-house dosimetric QA and validation for IMRT treatments.
A typical IMRT verification procedure consists of both absolute and relative phantom dosimetry (Verellen et al 1997 , Chang et al 2000 .
Relative phantom dosimetry is well established nowadays (Chang et al 2000 , Arnfield et al 2001 , Sánchez-Doblado et al 2001 , Ting and Davis 2001 , Depuydt et al 2002 . However, the recommended procedures for absolute dosimetry in reference conditions (Almond et al 1999 , Andreo et al 2000 cannot be applied in these special situations (Rice et al 1987 , Bjärngard et al 1990 , Núñez and Sánchez-Doblado 1999 , Martens et al 2000 , Westermark et al 2000 , Saitoh et al 2002 , Paskalev et al 2002 , 2003 . The measurement conditions during the IMRT verification may be quite different from the reference conditions, so dosimetry of these narrow photon beams pertains to the so-called non-reference conditions for beam calibration. Special care must be taken when choosing the correction factors to convert the ionization reading of the ion chamber into the dose in water (Paskalev et al 2002 , 2003 , Capote et al 2004 , Sánchez-Doblado et al 2005 .
The dosimetry of the IMRT beamlets and the IMRT clinical dosimetry when evaluating the dose in the planning target volume (PTV) have been studied recently by an accurate Monte Carlo (MC) simulation. While dose correction factor for dose measurements outside the IMRT field could reach 9% (Capote et al 2004) , we found non-reference conditions to have a negligible clinical impact on the measured dose error in the PTV region (Sánchez-Doblado et al 2005) .
We consider the MC method, and particularly the EGSnrc transport system (Kawrakow and Rogers 2000 , Kawrakow 2000a , 2000b , as the most precise way to estimate how we should correct the ion-chamber reading for measurements far from reference conditions. A high accuracy of the MC calculations for medical dosimetry was demonstrated in recent applications (Buckley et al 2003 , Verhaegen 2002 , 2003 . The present work aims at estimating by the MC method the error made when measuring the organ at risk's (OAR) absolute dose by a micro ion chamber (µIC) in a typical IMRT treatment. Usually OAR regions are located in the penumbra or completely outside the IMRT beamlets. Therefore the dosimetric conditions in OAR could be quite different from the reference conditions. The dose error comes from the assumption that the dosimetric parameters determining the absolute dose are the same as those for the reference conditions. 
Materials and methods

Clinical cases
To evaluate the dose correction factor for non-reference conditions at OARs we selected two different clinical cases. The first was the prototype IMRT treatment used by the QUASIMODO team (QUality ASsurance Intensity MODulated RadiOtherapy 6 ) to check the CarPet phantom performance (mainly developed by C De Wagter and P Williams). Figure 1 shows the CarPet phantom (a) and the virtual horseshoe shape PTV around a cylindrical OAR (b). The IMRT solution proposed by our team, as a member of the QUASIMODO task group, consisted of nine coplanar beams at different angles. We obtained at the OAR approximately 55% of the dose delivered to the PTV, as can be seen in figure 2. The positions of some representative segments with respect to the isocentre, where the ionization chamber was placed, are presented in the scatter maps of figure 3. We have considered three different cases for analysis. 2. A group of beamlets, where the ionization chamber located at the isocentre is fully covered by the incident beams (figures 3(e)-(g), superimposed in figure 4 left). We named this group on-axis beamlets. 3. A full IMRT treatment (superposition of the two previous cases).
In our QUASIMODO treatment, we deliver a significant dose to the isocentre, which is coming from on-axis beamlets. These dosimetric conditions are similar to the reference conditions, so we expect that dose error will be small in this case.
We have selected a very special second real clinical case, where the studied OAR is the rectum. The PTV is enclosing the OAR, like a circular crown in every CT slice (figure 5). The IC is located at the isocentre inside OAR, being completely outside the IMRT beamlets. We expect this situation to be a worst-case scenario, where the greatest difference from reference conditions is achieved. The patient treatment consists of 46.8 Gy plus a boost of 30.6 Gy with 1.8 Gy/day for a radical intention in a prostate carcinoma. The IMRT treatment with seven coplanar beam angles has been used featuring 20 segments. This solution was derived by a forward optimization method (Arrans et al 2003) , obtaining a dose distribution in the patient and in the cylindrical model, shown in figure 6. The dose at the isocentre (OAR), where the ionization chamber is located, represents only about 15% of the PTV dose as can be seen in the bottom part of figure 6. Table 1 summarizes the entry angles, number of segments and monitor units per field for both studied IMRT treatments.
Accelerator and collimator
A 6 MV photon beam produced by a Siemens Primus accelerator has been employed in this study. This accelerator is a dual photon linac equipped with a multileaf collimator (MLC) 6 22
Figure 4. Superposition of the scatter diagrams is presented on the left for all on-axis beamlets, in terms of the particle density at the phase space plane, which is 60.8 cm away from the target ((e)-(g) in figure 3 ). On the right, the same for the off-axis beamlets ((a)-(d) in figure 3 ). The numbers in the squares at the upper-right corner of the drawings indicate the total number of on-axis or off-axis beamlets superposed. The (red) cross marks the isocentre, where the IC is located.
used for IMRT treatments. The MLC has 29 opposed leaf pairs, the outer leaves of each bank project a shadow width of 6.5 cm in the isocentre plane, while the inner 27 leaf pairs project a width of 1 cm. Both leaf end and leaf side match the beam divergence, making the configuration double-focused.
TPS and ionization chamber
The TPS used for the implementation of the IMRT treatments was a Helax TMS 6.1a. The IBA-Wellhöfer NAC 007 micro ionization chamber 7 , used for IMRT quality assurance in our hospital, with an active volume equal to 0.007 cm 3 was simulated using a cylindrical model as shown in figure 7 (bottom). A detailed description of the simulation model was given in our previous paper (Capote et al 2004) . In our simulation, the chamber axis was always coincident with the phantom axis and perpendicular to the beam axis as shown in the upper part of figure 7. The centre of the ionization chamber (assumed to be located at the top of the electrode) was positioned at 12 cm (10 cm for the reference field) on the axis of a cylindrical water phantom with a radius of 12 cm (10 cm for the reference field) and height of 24.3 cm.
Dose total correction factor f water, air
In recent studies (Paskalev et al 2002 , 2003 , Capote et al 2004 a total correction factor was introduced into the IC reading being equal to the ratio of the dose in water to the dose deposited within the air cavity as it was suggested by Nahum (1988) :
where water is the irradiated medium and air is the material contained in the detector cavity. The MC estimator of the f water,air using the full ion-chamber model was discussed in our previous paper (Capote et al 2004) . We also introduced the correction factor c to convert the IC reading for 6 MV beam from reference into non-reference conditions. This correction 
Monte Carlo calculations
The BEAMnrc Monte Carlo code (Nelson et al 1985 , Rogers et al 1995 , Kawrakow and Rogers 2000 , Kawrakow et al 2000a , 2000b has been used to simulate the radiation transport through the Siemens Primus accelerator configurations. Phase spaces characterizing the beams were obtained first, just above the jaws of the accelerator. These were used as input for the subsequent simulations through the whole collimator system (including the MLC collimator), yielding the phase space in air before entering the water phantom surface. The data were scored in a plane perpendicular to the beam axis, at 60.8 cm from the accelerator target for the IMRT beamlets and at 90 cm for the standard 10 × 10 cm 2 reference field. The Siemens Primus accelerator simulation was already validated with experimental measurements in the previous work , showing excellent agreement. Therefore, we can be confident that the accelerator-collimator system was simulated with a high accuracy. The stored phase space files were rotated by 90
• around the ion-chamber centre (ISOURCE = 22 option was employed). They were used as input to calculate the dose measured by the ion chamber positioned at 12 cm depth for IMRT treatments (10 cm depth for the reference 10 × 10 field).
The ionization chamber simulation model was described in our previous paper (Capote et al 2004) . We employed a CAVRZnrc user code which is an offspring with the cylindrical geometry of the CAVITY user code (Bielajew et al 1985, Rogers and Bielajew 1990) . The number of histories simulated was chosen so that the type A uncertainty of the dose in the active volume of the chamber within the beam was below 1% in all cases. The CPU time required for the calculations was drastically reduced by the use of a Linux cluster with 87 personal computers (47 Pentium III 1.1 GHz and 40 Pentium IV 2.4 GHz), capable of running processes simultaneously and using an in-house specific model for the distribution of the simulation tasks (Sánchez-Doblado et al 2000, Leal et al 2004) .
Results and discussion
The calculated doses delivered inside the IC's active volume filled with water as well as the corresponding dose ratio D water /D air , i.e. the total IC correction factor f water,air and the correction factor c (ratio of the f water,air factors for reference and non-reference irradiation conditions) for all studied cases are shown in table 2. In the CarPet phantom, the largest correction factor c = 0.96 ± 0.03 is obtained for the off-axis group of 22 beamlets (see figure 4 right for the superposition of scatter diagrams of these beamlets). The overall dose contribution of this group is only 13 out of 199 cGy, which is the total dose delivered to isocentre. The largest contribution to the isocentre dose is, by far, the one coming from the on-axis group of six beamlets (represented in figure 4 left), which amounts to 186 cGy. The correction factor c = 0.97 ± 0.02, derived for this second group of beamlets, is slightly different from unity within uncertainty. It coincides with the correction factor calculated for the total dose measured by IC at the isocentre in the OAR region, as can be seen in table 2.
In the prostate carcinoma case we have an annular shaped PTV, enclosing the rectum as the OAR. For the applied IMRT treatment the isocentre, located within the OAR, is always outside the incident beams; therefore larger dosimetric errors could be expected. However, the derived correction factor c is equal to unity (with a 3% uncertainty).
Overall, we can state that the error in the OAR dose, arising from the assumption that the dosimetric parameters determining the absolute dose are the same as those for the reference conditions, is negligible within the uncertainty for the studied IMRT cases. We do not expect these results to depend on the simulated ion chamber as long as similar small chambers are used for measurements. However, additional simulations may be required to prove this point. These results hold for step-and-shoot IMRT; however its applicability to different IMRT deliveries should be studied. Table 2 . D water represents the Monte Carlo estimation of the true delivered dose per session deposited within the ion chamber's active volume filled with water. f water,air is the total correction factor needed to convert the ion-chamber readings into the dose in water. A correction factor c (Capote et al 2004) is given in the last column. It characterizes a change in the total correction factor f water,air between reference and no-reference conditions. The type A uncertainty of the calculated dose and correction factors is listed in parentheses as a relative estimation in per cent of the value. 
Summary and conclusions
Absolute dosimetry with a micro ion chamber at the OAR position for step-and-shoot IMRT treatments has been addressed using Monte Carlo methods. We observed small differences in the correction factor c from unity for the complete IMRT treatment in the case of the CarPet phantom. The incurred absolute dose error is negligible from the clinical point of view. No dose error was found in the studied prostate carcinoma case, if we use correction factors derived for reference conditions to calculate the dose measured at the OAR. We previously found that the physical dosimetry in the penumbra region of the IMRT beamlet, as can occur in the OAR dosimetry, can suffer from considerably higher errors (Capote et al 2004) . Further research on this subject covering different types of ion chambers as well as different IMRT deliveries is warranted.
